Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Randomized, Placebo Controlled, Double-Blind Study to Confirm Efficacy and Safety of Terlipressin in Subjects With Hepatorenal Syndrome Type 1 (The CONFIRM Study)

NCT02770716 is registered in ClinicalTrials.gov with Mallinckrodt as lead sponsor.

NCT NCT02770716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02770716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Randomized, Placebo Controlled, Double-Blind Study to Confirm Efficacy and Safety of Terlipressin in Subjects With Hepatorenal Syndrome Type 1 (The CONFIRM Study)
Lead sponsor
Mallinckrodt
Phase
Phase 3
Overall status
Completed
Start date
July 13, 2016
Completion date
July 24, 2019
Enrollment
300 (actual)
Sites
64

Conditions

As the registry lists them; a condition with its own page is linked.

hepatorenal syndrome